These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5163428)

  • 1. Comparative cytogenetic study of the resistance of tumor cells to sarcolysine.
    Voitovitskii VK; Edygenova AK; Kabiev OK
    Sov Genet; 1971 Jun; 7(6):766-9. PubMed ID: 5163428
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chromosome characteristics of tumors during changes in drug resistance (experimental study)].
    Voĭtovitskiĭ VK; Edygenova AK; Kabiev OK
    Vopr Onkol; 1973; 19(1):77-82. PubMed ID: 4633875
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chromosome aberrations in cells of a thiophosphamide-resistant tumor arising during a single treatment with alkylating preparations and x-rays].
    Voĭtovitskiĭ VK; Edygenova AK; Kabiev OK
    Tsitologiia; 1971 Oct; 13(10):1272-9. PubMed ID: 5002495
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.
    Caffrey PB; Zhang Y; Frenkel GD
    Anticancer Res; 1998; 18(4C):3021-5. PubMed ID: 9713503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the circadian rhythm of cell division in the action of sarcolysine on transplantable rat sarcomas].
    Svinogeeva TP; Kharlampovich SI
    Vopr Onkol; 1973; 19(12):62-5. PubMed ID: 4786892
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of human ovarian tumor xenografts with selenite prevents the melphalan-induced development of drug resistance.
    Caffrey PB; Frenkel GD
    Anticancer Res; 1998; 18(4C):3017-20. PubMed ID: 9713502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of sarcolysine on utilization of H3-thymidine by cells of transplantable tumors in vitro].
    Kas'ianenko VV
    Vopr Onkol; 1968; 14(1):51-5. PubMed ID: 5660341
    [No Abstract]   [Full Text] [Related]  

  • 8. Caffeine effects on the chromosomal aberrations induced in vivo by sarcolysine and methotrexate.
    Georgian L; Moraru I; Comişel V
    Morphol Embryol (Bucur); 1980; 26(2):179-83. PubMed ID: 6446036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of the development of melphalan resistance in vitro by selenite.
    Caffrey PB; Zhu M; Frenkel GD
    Biol Trace Elem Res; 1998 Dec; 65(3):187-95. PubMed ID: 9892492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Marker chromosomes in the karyotype of cells of the NK-Ly ascitic tumor].
    Poroshenko GG; Nikol'skaia TA
    Dokl Akad Nauk SSSR; 1967 May; 174(1):210-2. PubMed ID: 5622446
    [No Abstract]   [Full Text] [Related]  

  • 11. Ploidy fluctuations of mouse plasma-cell neoplasm MSPC-1 during serial transplantation.
    Moriwaki K; Imai HT; Yamashita J; Yosida TH
    J Natl Cancer Inst; 1971 Sep; 47(3):623-37. PubMed ID: 5157581
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factors responsible for increasing the cytogenetic effectiveness of cyclophosphamide administered to irradiated animals. Cytogenetic effect of mutagens not requiring metabolic activation on bone marrow cells of irradiated rats].
    Iakovleva TK; Barkan RS
    Radiobiologiia; 1983; 23(4):536-8. PubMed ID: 6611883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on crocker sarcoma under the effect of alkylating agents. 3. Morphological and karyometrical studies of sarcoma 180 after treatment with antitumour drug DL-sarcolysine.
    el-Fiky SM; Taha YM
    Gegenbaurs Morphol Jahrb; 1973; 119(1):34-46. PubMed ID: 4710025
    [No Abstract]   [Full Text] [Related]  

  • 14. [On sensitivity to sarcolysine of Ehrlich's ascites tumors in mice "vaccinated" with treated tumor cells from animals previously treated with sarcolysine alone or with other antineoplastic drugs (thioguanine, actinomycin D)].
    Bonmassar E; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):229-44. PubMed ID: 5745130
    [No Abstract]   [Full Text] [Related]  

  • 15. [The concentration of endogenous sulfhydryl groups in the cells of ascitic tumors during their growth].
    Ismailov BI; Zhemaletdinov FG; Efimov ML; Arkhipova LD; Krasnoshtanov VK
    Vopr Onkol; 1971; 17(4):99-101. PubMed ID: 5109397
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radiosensitivity and content of endogenous SH-groups and reduced glutathione in rat ovarian ascites tumor and its cloned sublines].
    Ismailov BI; Zhemaletdinov FG
    Radiobiologiia; 1972; 12(1):52-7. PubMed ID: 5031436
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rearrangements in cell populations in malignant growth].
    Shuklinov VA
    Eksp Onkol; 1984; 6(6):25-30. PubMed ID: 6396066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effeco of sarcolysine on the growth and morphological characteristics of IMR-1 sarcoma].
    Svinogeeva TP; Kharlampovich SI
    Vopr Onkol; 1974; 20(4):98-9. PubMed ID: 4439824
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative cytogenetic study of melphalan-sensitive and -resistant murine L1210 leukemia cells.
    Schuette BP; Rabinovitz M; Vistica DT
    Cancer Lett; 1980 Feb; 8(4):335-41. PubMed ID: 6929219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A quantitative histochemical study of DNA and total protein in the livers of rats with transplantable ovarian tumor (strain OIa)].
    Ismailov BI; Arkhipova LD; Efimov ML
    Vopr Onkol; 1970; 16(1):113-4. PubMed ID: 5461572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.